We Can Cure Ebola! (Mostly—Which Is Better Than Rarely) | SciShow News

The video discusses the second largest Ebola outbreak and the introduction of new treatments that significantly reduce mortality rates. Clinical trials in the Democratic Republic of the Congo tested new drugs, including antibodies REGN-EB3 and MAB 114, which showed promising results. The video also covers advancements in treating antibiotic-resistant tuberculosis, highlighting the FDA-approved drug pretominid, which, when combined with other antibiotics, improves recovery rates. Challenges remain in making these treatments accessible and affordable, especially in impoverished areas.

What is the significance of the FDA's approval of new treatments for tuberculosis?

What was the outcome of the clinical trial for the antibiotic pretominid combined with other antibiotics?